Literature DB >> 16125464

Where do we stand on the autoimmunity hypothesis of Chagas disease?

Felipe Kierszenbaum1.   

Abstract

The question posed in the title elicits as much controversy today as it did when I wrote about this subject in the first issue of Parasitology Today 20 years ago. A consensus is now emerging that Trypanosoma cruzi, the etiological agent of Chagas disease, bears primary responsibility for producing chagasic pathology. Whether one or more of the autoimmune events described in human and experimental Chagas disease can contribute to, or aggravate, this pathology is the current question.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125464     DOI: 10.1016/j.pt.2005.08.013

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  33 in total

Review 1.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 2.  Current concepts in immunoregulation and pathology of human Chagas disease.

Authors:  Walderez O Dutra; Kenneth J Gollob
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

3.  Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease.

Authors:  Walderez Ornelas Dutra; Cristiane Alves Silva Menezes; Fernanda Nobre Amaral Villani; Germano Carneiro da Costa; Alexandre Barcelos Morais da Silveira; Débora d'Avila Reis; Kenneth J Gollob
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

Review 4.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 5.  Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop.

Authors:  Dori Germolec; Dwight H Kono; Jean C Pfau; K Michael Pollard
Journal:  J Autoimmun       Date:  2012-06-27       Impact factor: 7.094

6.  Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.

Authors:  Jaline Coutinho Silverio; Luzia Maria de-Oliveira-Pinto; Andréa Alice da Silva; Gabriel Melo de Oliveira; Joseli Lannes-Vieira
Journal:  Int J Exp Pathol       Date:  2009-10-28       Impact factor: 1.925

Review 7.  New perspectives in the diagnosis and management of enteric neuropathies.

Authors:  Charles H Knowles; Greger Lindberg; Emanuele Panza; Roberto De Giorgio
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-12       Impact factor: 46.802

8.  Chemotherapy of chronic indeterminate Chagas disease: a novel approach to treatment.

Authors:  Paola Carolina Bazán; María Silvina Lo Presti; Héctor Walter Rivarola; María Fernanda Triquell; Ricardo Fretes; Alicia Ruth Fernández; Julio Enders; Patricia Paglini-Oliva
Journal:  Parasitol Res       Date:  2008-05-31       Impact factor: 2.289

9.  Allopurinol is effective to modify the evolution of Trypanosoma cruzi infection in mice.

Authors:  Paola Gobbi; María S Lo Presti; Alicia R Fernández; Julio E Enders; Ricardo Fretes; Susana Gea; Patricia A Paglini-Oliva; Héctor W Rivarola
Journal:  Parasitol Res       Date:  2007-07-10       Impact factor: 2.289

10.  Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.

Authors:  Ivonne D Flechas; Adriana Cuellar; Zulma M Cucunubá; Fernando Rosas; Víctor Velasco; Mario Steindel; María del Carmen Thomas; Manuel Carlos López; John Mario González; Concepción Judith Puerta
Journal:  BMC Infect Dis       Date:  2009-11-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.